PharmTech

Charles River Launches Off-the-Shelf Rep/Cap Plasmids for AAV Vector Manufacturing

Charles River’s off-the-shelf rep/cap plasmids are intended to simplify gene therapy supply chains. Charles River Laboratories International announced the launch of its off-the-shelf ...
Yahoo Finance

AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics

WEST JEFFERSON, OH and GAITHERSBURG, MD / ACCESSWIRE / October 31, 2023 / AmplifyBio, a leading service provider for the commercialization of advanced modality therapeutics, and Vector BioMed, a ...
Business Wire

Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline ...
PharmiWeb

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a ...
Yahoo Finance

Global Viral Vector & Plasmid DNA Manufacturing Market Report 2021 - Rising Use of Viral Vectors in Several Treatments Demands Developments in Plasmids and Vectors

Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Workflow, by Application, by End User - Global Forecast to 2025 - Cumulative ...